000 00963 a2200253 4500
005 20250517175333.0
264 0 _c20181105
008 201811s 0 0 eng d
022 _a1474-4457
024 7 _a10.1016/S1473-3099(17)30539-X
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrotherton, Julia M L
245 0 0 _aConfirming cross-protection of bivalent HPV vaccine.
_h[electronic resource]
260 _bThe Lancet. Infectious diseases
_c12 2017
300 _a1227-1228 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aCross Protection
650 0 4 _aHumans
650 0 4 _aPapillomavirus Infections
_ximmunology
650 0 4 _aPapillomavirus Vaccines
_ximmunology
650 0 4 _aUterine Cervical Neoplasms
_xprevention & control
773 0 _tThe Lancet. Infectious diseases
_gvol. 17
_gno. 12
_gp. 1227-1228
856 4 0 _uhttps://doi.org/10.1016/S1473-3099(17)30539-X
_zAvailable from publisher's website
999 _c27619763
_d27619763